227 related articles for article (PubMed ID: 21852088)
1. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Lee SH; Lawson D; Baek SJ
J Nutr Biochem; 2012 Aug; 23(8):915-23. PubMed ID: 21852088
[TBL] [Abstract][Full Text] [Related]
2. Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells.
Aziz MY; Omar AR; Subramani T; Yeap SK; Ho WY; Ismail NH; Ahmad S; Alitheen NB
Oncol Lett; 2014 May; 7(5):1479-1484. PubMed ID: 24765160
[TBL] [Abstract][Full Text] [Related]
3. Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation.
Sukamporn P; Rojanapanthu P; Silva G; Zhang X; Gritsanapan W; Baek SJ
Life Sci; 2016 May; 152():60-6. PubMed ID: 27018445
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive and anti-inflammatory action of the CHCl3-soluble phase and its main active component, damnacanthal, isolated from the root of Morinda citrifolia.
Okusada K; Nakamoto K; Nishida M; Fujita-Hamabe W; Kamiya K; Mizushina Y; Satake T; Tokuyama S
Biol Pharm Bull; 2011; 34(1):103-7. PubMed ID: 21212526
[TBL] [Abstract][Full Text] [Related]
5. Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies.
Mohd MR; Ariff TM; Mohamad N; Abdul Latif AZ; Wan Nik WMN; Mohamed A; Suffian IFM
Pak J Pharm Sci; 2019 Sep; 32(5):2155-2162. PubMed ID: 31813882
[TBL] [Abstract][Full Text] [Related]
6. Morindone as a potential therapeutic compound targeting TP53 and KRAS mutations in colorectal cancer cells.
Chee CW; Mohd Hashim N; Nor Rashid N
Chem Biol Interact; 2024 Apr; 392():110928. PubMed ID: 38423379
[TBL] [Abstract][Full Text] [Related]
7. Damnacanthal-induced anti-inflammation is associated with inhibition of NF-κB activity.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Kwankitpraniti T; Min KW; Baek SJ
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):455-63. PubMed ID: 21999179
[TBL] [Abstract][Full Text] [Related]
8. NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3.
Lee SH; Krisanapun C; Baek SJ
Carcinogenesis; 2010 Apr; 31(4):719-28. PubMed ID: 20110283
[TBL] [Abstract][Full Text] [Related]
9. Morindone from Morinda citrifolia as a potential antiproliferative agent against colorectal cancer cell lines.
Chee CW; Zamakshshari NH; Lee VS; Abdullah I; Othman R; Lee YK; Mohd Hashim N; Nor Rashid N
PLoS One; 2022; 17(7):e0270970. PubMed ID: 35819953
[TBL] [Abstract][Full Text] [Related]
10. Damnacanthal: a promising compound as a medicinal anthraquinone.
Abu N; Ali NM; Ho WY; Yeap SK; Aziz MY; Alitheen NB
Anticancer Agents Med Chem; 2014 Jun; 14(5):750-5. PubMed ID: 24164045
[TBL] [Abstract][Full Text] [Related]
11. Effects of Damnacanthal and Nordamnacanthal on Proliferation, Apoptosis, and Migration of Oral Squamous Cell Carcinoma Cells.
Shaghayegh G; Alabsi AM; Ali-Saeed R; Ali AM; Vincent-Chong VK; Ismail NH; Choon YF; Zain RB
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3333-3341. PubMed ID: 29286228
[TBL] [Abstract][Full Text] [Related]
12. The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects.
García-Vilas JA; Pino-Ángeles A; Martínez-Poveda B; Quesada AR; Medina MÁ
Cancer Lett; 2017 Jan; 385():1-11. PubMed ID: 27816491
[TBL] [Abstract][Full Text] [Related]
13. Damnacanthal inhibits the NF-κB/RIP-2/caspase-1 signal pathway by inhibiting p56lck tyrosine kinase.
Kim MH; Jeong HJ
Immunopharmacol Immunotoxicol; 2014 Oct; 36(5):355-63. PubMed ID: 25139491
[TBL] [Abstract][Full Text] [Related]
14. An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni).
Pawlus AD; Su BN; Keller WJ; Kinghorn AD
J Nat Prod; 2005 Dec; 68(12):1720-2. PubMed ID: 16378361
[TBL] [Abstract][Full Text] [Related]
15. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Potential of Damnacanthal and Nordamnacanthal from
Latifah SY; Gopalsamy B; Abdul Rahim R; Manaf Ali A; Haji Lajis N
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808969
[TBL] [Abstract][Full Text] [Related]
17. Damnacanthal inhibits IgE receptor-mediated activation of mast cells.
Garcia-Vilas JA; Medina MA; Melo FR; Pejler G; Garcia-Faroldi G
Mol Immunol; 2015 May; 65(1):86-93. PubMed ID: 25656801
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of damnacanthal isolated from roots of Morinda elliptica.
Alitheen NB; Manaf AA; Yeap SK; Shuhaimi M; Nordin L; Mashitoh AR
Pharm Biol; 2010 Apr; 48(4):446-52. PubMed ID: 20645725
[TBL] [Abstract][Full Text] [Related]
20. A new anthraquinone from Morinda citrifolia roots.
Ee GC; Wen YP; Sukari MA; Go R; Lee HL
Nat Prod Res; 2009; 23(14):1322-9. PubMed ID: 19735047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
